Michael R. McDonnell
Director · Moderna, Inc.
- 2025
- Jul 10, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael R. McDonnell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephane Bancel - $28.72M in MRNA purchases and sales in the last 12 months
- Stephen Hoge - $28.43M in MRNA purchases and sales in the last 12 months
- Fred P. Lampropoulos - $5.19M in MMSI purchases and sales in the last 12 months
- James M. Mock - $4.69M in MRNA purchases and sales in the last 12 months
- Neil Peterson - $2.95M in MMSI purchases and sales in the last 12 months
- Shannon Thyme Klinger - $1.39M in MRNA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael R. McDonnell?
Michael R. McDonnell is a corporate insider, tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael R. McDonnell last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 6 filings going back to 2025.
Has Michael R. McDonnell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($330K) across all tracked filings.
